title: Early treatment of tetanus-induced trismus with botulinum toxin A.
authors.forename: Helle
authors.initials: H
authors.lastname: Herrman
authors.forename: Anne
authors.initials: A
authors.lastname: Braekhus
authors.forename: Olaf
authors.initials: O
authors.lastname: Aaserud
authors.forename: Pål
authors.initials: P
authors.lastname: Aukrust
authors.forename: Audun
authors.initials: A
authors.lastname: Stubhaug
authors.forename: Bjørnar
authors.initials: B
authors.lastname: Hassel
mesh_terms: D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000931:Antidotes / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008795:Metronidazole / Q000627:therapeutic use; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D013742:Tetanus / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D013743:Tetanus Antitoxin / Q000627:therapeutic use; D016896:Treatment Outcome; D014313:Trismus / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000890:Anti-Infective Agents; D000931:Antidotes; D009465:Neuromuscular Agents; D013743:Tetanus Antitoxin; D008795:Metronidazole; D019274:Botulinum Toxins, Type A